← Back to Conditions

Thrombocytosis

disorder
SNOMED 6631009CUI C0836924

Overview

Source: MedlinePlus.gov, National Library of Medicine. Not a substitute for medical advice.

Treatments & Interventions

Uramustine

substance

Anagrelide hydrochloride

substance

Anagrelide

substance

Chlorambucil

substance

Clinical Trials

1
Total Trials
0
Recruiting
1
With Results

Recent Trials

Exploratory Phase II Study of INC424 Patients With Primary Myelofibrosis (PMF) or Post Polycythaemia Myelofibrosis (PPV MF) or Post Essential Thrombocythaemia Myelofibrosis (PET-MF)

NCT01558739Phase 4Completed48 enrolled
View all 1 trials on ClinicalTrials.gov

Related Conditions

Post-splenectomy thrombocytosis(child)
Essential thrombocythemia (clinical disorder)(child)
Secondary thrombocytosis(child)
Familial thrombocytosis(child)
Familial thrombocytosis with transverse limb defect(child)
Platelet disorder(parent)

Quick Facts

SNOMED CT
6631009
UMLS CUI
C0836924
Fully Specified Name
Thrombocytosis (disorder)
Specialists
0
Diagnostic Biomarkers
0
Known Treatments
4
Clinical Trials
1
Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Clinical content is derived from the SNOMED CT clinical ontology and curated medical knowledge graphs.